Bacterial vaginosis: Etiology and modalities of treatment - A brief note

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 4, 2011, Pages 496-503

  Kumar, Nikhil ^a   Behera, Beauty ^a   Sagiri, Sai S ^a   Pal, Kunal ^a   Ray, Sirsendu S ^a   Roy, Saroj ^b  

^a NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

Author keywords

Antimicrobials; bacterial vaginosis; lactobacilli; probiotics; sexual intercourse; vagina

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CARBOMER; CHITOSAN; CLINDAMYCIN; FLUCONAZOLE; LACTIC ACID; METRONIDAZOLE; NITROIMIDAZOLE; PENICILLIN G; PROBIOTIC AGENT; TINIDAZOLE; YOGHURT;

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFECT; DRUG FORMULATION; GARDNERELLA VAGINALIS; GROWTH INHIBITION; HUMAN; MILK; MOLECULAR PATHOLOGY; MYCOPLASMA; MYCOPLASMA CURTISII; MYCOPLASMA HOMINIS; NONHUMAN; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; VAGINA FLORA; VAGINITIS;

BACTERIA (MICROORGANISMS);

EID: 84865526617     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.90102     Document Type: Review

References (106)

1. Owen JA Jr. Physiology of the menstrual cycle. Am J Clin Nutr 1975;28:333-8.
2. Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000;183:967-73.
3. Wagner G, Ottesen B. Vaginal physiology during menstruation. Ann Intern Med 1982;96:921-3.
4. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 2000;30:901-7.
5. Shi Y, Chen L, Tong J, Xu C. Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods. J Obstet Gynaecol Res 2009;35:525-32.
6. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004;150:2565-73.
7. Hawthorn LA, Bruce AW, Reid G. Ability of uropathogens to bind to Tamm Horsfall protein-coated renal tubular cells. Urol Res 1991;19:301-4.
8. Otero CM, Nader-Macías EM. Lactobacillus adhesion to epithelial cells from bovine vagina. Commun Curr Res Educ Top Trends App Microbiol 2007;2:749-57.
9. Busscher HJ, Weerkamp AH. Specific and non-specific interactions in bacterial adhesion to solid substrata. FEMS Microbiol Lett 1987;46:165-73.
10. Bibel DJ, Aly R, Lahti L, Shinefield HR, Maibach HI. Microbial adherence to vulvar epithelial cells. J Med Microbiol 1987;23:75-82.
11. Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 2006;273:195-202.
12. Kamarashev JA, Vassileva SG. Dermatologic diseases of the vulva. Clin Dermatol 1997;15:53-65.
13. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52 Suppl 1:S46-52.
14. Andersen PH, Bucher A P, Saeed I, Lee PC, Davis JA, Maibach HI. Faecal enzymes: In vivo human skin irritation. Contact Dermatitis 1994;30:152-8.
15. Warren R, Bauer A, Greif C, Wigger-Alberti W, Jones MB, Roddy MT, et al. Transepidermal water loss dynamics of human vulvar and thigh skin. Skin Pharmacol Physiol 2005;18:139-43.
16. Faergemann J, Aly R, Wilson DR, Maibach HI. Skin occlusion: effect on Pityrosporum orbiculare, skin PCO2, pH, transepidermal water loss, and water content. Arch dermatol Res 1983;275:383-7.
17. Freinkel RK, Shen Y. The origin of free fatty acids in sebum. II. Assay of the lipases of the cutaneous bacteria and effects of pH. J Invest Dermatol 1969;53:422-7.
18. Elias P. The skin barrier as an innate immune element. Semin Immunopathol 2007;29:3-14.
19. Farage M, Bramante M, Otaka Y, Sobel J. Do panty liners promote vulvovaginal candidiasis or urinary tract infections?: A review of the scientific evidence. Eur J Obstet Gynecol Reproduct Biol 2007;132:8-19.
20. Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes JA, et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 2001;185:375-9.
21. Nieman C. Influence of trace amounts of fatty acids on the growth of microorganisms. Bactorial Rev1954;18:147-63.
22. Kabara JJ, Swieczkowski DM, Conley AJ, Truant J P. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 1972;2:23-8.
23. Brook I. Bacterial Interference. Crit Rev Microbiol 1999;25:155-72.
24. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 2002;4:319-24.
25. Osset J, Bartolomé RM, García E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183:485-91.
26. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol 2003;69:18-23.
27. Pommerenke WT, Taylor PW Jr. Antibacterial properties of vaginal and cervical secretions and amniotic fluid. Ann Ostet Ginecol 1953;75:891-9.
28. Cavallo G. Vaginal microbial flora and infectious pathology. G Batteriol Virol Immunol 1987;80:277-95.
29. Ouattara B, Simard RE, Holley RA, Piette GJ, Bégin A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol 1997;37:155-62.
30. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
31. Casadevall A, Pirofski LA. Host-pathogen interactions: Basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun 2000;68:6511-8.
32. Boris S, Suárez JE, Vázquez F, Barbés C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998;66:1985-9.
33. Coconnier MH, Klaenhammer TR, Kernéis S, Bernet M F, Servin AL. Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl Environ Microbiol 1992;58:2034-9.
34. Conway PL, Kjelleberg S. Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium. J Gen Microbiol 1989;135:1175-86.
35. Bernet M F, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 1993;59:4121-8.
36. Sherman LA, Savage DC. Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Appl Environ Microbiol 1986;52:302-4.
37. Granato D, Perotti F, Masserey I, Rouvet M, Golliard M, Servin A, et al. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl Environ Microbiol 1999;65:1071-7.
38. Neeser JR, Granato D, Rouvet M, Servin A, Teneberg S, Karlsson KA. Lactobacillus johnsonii La 1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 2000;10:1193-9.
39. Lowbury EJ, Lilly HA, Bull J P. Disinfection of Hands: Removal of Transient Organisms. Br Med J 1964;2:230-3.
40. Lepargneur J P, Rousseau V. Protective role of the Doderleïn flora. J Gynecol Obstet Biol Reprod (Paris) 2002;31:485-94.
41. Bartlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, Alpert S, et al. Quantitative Bacteriology of the vaginal flora. J Infect Dis 1977;136:271-7
42. Hammerschlag MR, Alpert S, Onderdonk AB, Thurston P, Drude E, McCormack WM, et al. Anaerobic microflora of the vagina in children. Am J Obstet Gynecol 1978;131:853-6.
43. Bartlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, Alpert S, et al. Quantitative bacteriology of the vaginal flora J Infect Dis 1977;136:271-7.
44. Stoyancheva G, Danova S, Boudakov IY. Molecular identification of vaginal lactobacilli isolated from Bulgarian women. Antonie Van Leeuwenhoek 2006;90:201-10.
45. Lachlak N, Ageron E, Zampatti O, Michel G, Grimont PA. Composition of the Lactobacillus acidophilus complex isolated from vaginal flora. New Microbiol 1996;19:123-32.
46. Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. Vaginal Lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002;40:2746-9.
47. Hillier S. The complexity of microbial diversity in bacterial vaginosis. N Eng J Med 2005;353:1886-7.
48. Hill GB. The microbiology of bacterial vaginosis. Am J Obste Gynecol 1993;169:450-4.
49. Darwish A, Elnshar EM, Hamadeh SM, Makarem MH. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. J Obstet Gynaecol Res 2007;33:781-7.
50. Hillier SL, Nugent R P, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.
51. Afrakhteh M, Mahdavi A. Bacterial vaginosis and urinary tract infection. J Obstet Gynecol India 2007;57:513-6.
52. Hillier SL. The complexity of microbial diversity in bacterial vaginosis. N Engl J Med 2005;353:1886-7.
53. Money D. The laboratory diagnosis of bacterial vaginosis. Can J Infect Dis Med Microbiol 2005;16:77-9.
54. Wang J. Bacterial vaginosis. Primary Care Update for OB/GYNS. Prim Care Update Ob Gyns 2000;7:181-5.
55. Klebanoff MA, Nansel TR, Brotman RM, Zhang J, Yu K F, Schwebke JR, et al. Personal hygienic behaviors and bacterial vaginosis. Sex Transm Dis 2010;37:94-9.
56. Ryckman KK, Simhan HN, Krohn MA, Williams SM. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod 2009;15:131-7.
57. Spiegel CG. Bacterial vaginosis. Clin Microbiol Rev 1991;4:485-502.
58. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-911.
59. Hillier SL, Nugent R P, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.
60. Aruna K, Jyoti K. Role of bacterial vaginosis in preterm labor. J Obstet Gynecol India 2007;57:413-6.
61. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang L P, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 1998;12:1699-706.
62. Dunkelberg WE Jr. Diagnosis of hemophilus vaginalis vaginitis by gram-stained smears. Am J Obstet Gynecol 1965;91:998.
63. Joesoef M, Schmid G, Hillier S. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999;28 Suppl 1:S57-65.
64. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-9.
65. Adegboye T, Itiola O. Physical and release properties of metronidazole suppositories. Trop J Pharm Res 7:887-96.
66. Decena DC, Co JT, Manalastas RM Jr, Palaypayon E P, Padolina CS, Sison JM, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res 2006;32:243-51.
67. Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: Impact on fastidious bacteria. BMC Infect Dis 2009;9:89.
68. Dickey LJ, Nailor MD, Sobel JD. Guidelines for the treatment of bacterial vaginosis: Focus on tinidazole. Ther Clin Risk Manag 2009;5:485-9.
69. Simoes JA, Aroutcheva AA, Shott S, Faro S. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gyneco 2001;9:41-5.
70. Nyirjesy P, McIntosh MJ, Gattermeir DJ, Schumacher RJ, Steinmetz JI, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. Am J Obstet Gynecol 2006;194:1277-82.
71. nd, Waller D P, et al. Tw o novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis. Antimicrob Agents Chemother 2002;46:2692-5.
72. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-59.
73. Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech 2006;7:104.
74. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004;191:1124-9.
75. Schwebke JR, Desmond RA. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol 2011;204:211.e1-6.
76. Yasin B, Pang M, Lehrer RI, Wagar EA. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp M Pathol 2003;74:190-5.
77. Lamont R F, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:516-22.
78. Donders G, Bellen G, Ausma J, Verguts L, Vaneldere J, Hinoul P, et al. The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis. Eur J Clin Microbiol Infect Dis 2011;30:59-63.
79. Ouwehand A, Salminen S, Isolauri E. Probiotics: An overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279-89.
80. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003;16:658-72.
81. Burton J P, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003;69:97-101.
82. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993;16 Suppl 4:S273-81.
83. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003;189:1202-8.
84. Mclean N, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-52.
85. Juárez Tomás MS, Ocaña VS, Wiese B, Nader-Macías ME. Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Microbiol 2003;52:1117-24.
86. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6.
87. Boris S, Suarez JE, Vazquez F, Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998;66:1985-9.
88. Hamdan IY, Mikolajcik EM. Acidolin: An antibiotic produced by Lactobacillus acidophilus. J Antibiot (Tokyo) 1974;27:631-6.
89. Abee T, Klaenhammer TR, Letellier L. Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane. Appl Environ Microbiol 1994;60:1006-13.
90. Anukam K, Reid G. Probiotics: 100 years (1907-2007) after Elie Metchnikoff's Observation. Kingsley C Anukam 2008:21.
91. Sieber R, Dietz U. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis. Int Dairy J 1998;8:599-607.
92. Hughes VL, Hillier SL. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet Gynecol 1990;75:244-8.
93. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immun Med Microbiol 2001;30:49-52.
94. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce A W, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microb Infect 2006;8:1450-4.
95. Tasdemir M, Tasdemir I, Tasdemir S, Tavukcuoglu S. Alternative treatment for bacterial vaginosis in pregnant patients; restoration of vaginal acidity and flora. Arch AIDS Res 1996;10:239-41.
96. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet Gynecol Scand 1993;72:17-9.
97. Chimura T, Funayama T, Murayama K, Numazaki M. Ecological treatment of bacterial vaginosis. Jap J Antibio 1995;48:432-6.
98. Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis]. Minerva Ginecol 2006;58:227-31.
99. Ehrström S, Daroczy K, Rylander E, Samuelsson C, Johannesson U, Anzén B, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect 2010;12:691-9.
100. Hummelen R, Changalucha J, Butamanya NL, Cook A, Habbema JD, Reid G. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynecol Obstet 2010;111:245-8.
101. Srinivasan U, Misra D, Marazita ML, Foxman B. Vaginal and oral microbes, host genotype and preterm birth. Med Hypotheses 2009;73:963-75.
102. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: A double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 2010;203:120.e1-6.
103. Marcone V, Rocca G, Lichtner M, Calzolari E. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynecol Obstet 2010;110:223-6.
104. Dover SE, Aroutcheva AA, Faro S, Chikindas ML. Natural antimicrobials and their role in vaginal health: A short review. Int J Probiotics Prebiotics 2008;3:219-30.
105. Matu MN, Orinda GO, Njagi EN, Cohen CR, Bukusi EA. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe 2010;16:210-5.
106. McMillan A, Dell M, Zellar M P, Cribby S, Martz S, Hong E, et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces 2011;86:58-64.